| 1 |
32308382 | Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice. | 2020 |
1 |
| 2 |
32460635 | Heparin mimics and fibroblast growth factor-2 fabricated nanogold composite in promoting neural differentiation of mouse embryonic stem cells. | 2020 Sep |
3 |
| 3 |
33043139 | Plasma and Urinary FGF-2 and VEGF-A Levels Identify Children at Risk for Severe Bleeding after Pediatric Cardiopulmonary Bypass: A Pilot Study. | 2020 Jun |
2 |
| 4 |
34035190 | Synergetic effect of growth factor and topography on fibroblast proliferation. | 2020 Nov 18 |
3 |
| 5 |
29305908 | Exostosin-like 2 regulates FGF2 signaling by controlling the endocytosis of FGF2. | 2018 Apr |
1 |
| 6 |
28082743 | Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway. | 2017 Jan 13 |
1 |
| 7 |
28221043 | Radiolabeled 111In-FGF-2 Is Suitable for In Vitro/Ex Vivo Evaluations and In Vivo Imaging. | 2017 Mar 6 |
1 |
| 8 |
26774761 | Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids. | 2016 Apr 1 |
2 |
| 9 |
27728816 | A shear-thinning hydrogel that extends in vivo bioactivity of FGF2. | 2016 Dec |
1 |
| 10 |
26034014 | Accelerated tissue integration into porous materials by immobilizing basic fibroblast growth factor using a biologically safe three-step reaction. | 2015 Dec |
7 |
| 11 |
26041143 | Heparin-conjugated alginate multilayered microspheres for controlled release of bFGF. | 2015 Jun 4 |
3 |
| 12 |
26276817 | Angiopoietin-1 prevents severe bleeding complications induced by heparin-like drugs and fibroblast growth factor-2 in mice. | 2015 Oct |
1 |
| 13 |
26370927 | Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair. | 2015 Dec |
3 |
| 14 |
24832898 | Characterization of FGF family growth factors concerning branching morphogenesis of mouse lung epithelium. | 2014 May |
1 |
| 15 |
23211448 | The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium. | 2013 Feb |
1 |
| 16 |
23395667 | Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury. | 2013 May 10 |
1 |
| 17 |
23498894 | Switching of cell growth/detachment on heparin-functionalized thermoresponsive surface for rapid cell sheet fabrication and manipulation. | 2013 Jun |
10 |
| 18 |
24307297 | Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium. | 2013 |
2 |
| 19 |
22302099 | The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist. | 2012 Apr |
1 |
| 20 |
22371501 | Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factor. | 2012 Apr 13 |
2 |
| 21 |
22657385 | Encapsulation of basic fibroblast growth factor by polyelectrolyte multilayer microcapsules and its controlled release for enhancing cell proliferation. | 2012 Jul 9 |
1 |
| 22 |
22924876 | Creating 3D angiogenic growth factor gradients in fibrous constructs to guide fast angiogenesis. | 2012 Oct 8 |
1 |
| 23 |
21140191 | Skin regeneration with fibroblast growth factor 2 released from heparin-conjugated fibrin. | 2011 Apr |
1 |
| 24 |
21296407 | Cell affinity for bFGF immobilized heparin-containing poly(lactide-co-glycolide) scaffolds. | 2011 May |
3 |
| 25 |
20136400 | Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis. | 2010 Jun |
3 |
| 26 |
20552727 | Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets. | 2010 Aug |
1 |
| 27 |
20823601 | Synthesis of N-heteroaroyl aminosaccharide derivatives as fibroblast growth factor 2 signaling modulators. | 2010 Sep |
3 |
| 28 |
21058638 | Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells. | 2010 Dec 13 |
1 |
| 29 |
19565481 | Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. | 2009 Jul |
2 |
| 30 |
17109210 | Antiangiogenic effect of bile acid acylated heparin derivative. | 2007 Jan |
2 |
| 31 |
17352757 | Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing. | 2007 Mar-Apr |
3 |
| 32 |
17580326 | Characterization of the surface immobilized synthetic heparin binding domain derived from human fibroblast growth factor-2 and its effect on osteoblast differentiation. | 2007 Dec 15 |
1 |
| 33 |
17662276 | Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. | 2007 Sep |
1 |
| 34 |
16146647 | Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. | 2006 Mar |
2 |
| 35 |
16614797 | Chitosan hydrogel as a drug delivery carrier to control angiogenesis. | 2006 |
1 |
| 36 |
16627026 | Raman spectroscopic evidence for octacalcium phosphate and other transient mineral species deposited during intramembranous mineralization. | 2006 Sep |
1 |
| 37 |
16858650 | Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. | 2006 Aug |
8 |
| 38 |
15943814 | FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8. | 2005 Jun |
2 |
| 39 |
16088988 | Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. | 2005 Jul 20 |
2 |
| 40 |
16229644 | Raman imaging demonstrates FGF2-induced craniosynostosis in mouse calvaria. | 2005 May-Jun |
3 |
| 41 |
14607508 | Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. | 2004 Feb |
2 |
| 42 |
15106730 | Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction. | 2004 Feb |
1 |
| 43 |
12579570 | Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. | 2003 Mar 1 |
2 |
| 44 |
12423248 | Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan. | 2002 Oct |
4 |
| 45 |
11436975 | Gradient micropattern immobilization of heparin and its interaction with cells. | 2001 |
4 |
| 46 |
11514538 | Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF(165) and VEGF(165).KDR Complexes. | 2001 Oct 26 |
1 |
| 47 |
10684625 | Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. | 2000 Feb 15 |
11 |
| 48 |
10850445 | Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis. | 2000 Jun 1 |
1 |
| 49 |
10397905 | Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. | 1999 Jan |
1 |
| 50 |
9558385 | Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. | 1998 May 1 |
1 |